Mass rollout of weight loss jabs begins on NHS
The mass rollout of weight loss jabs on the NHS in England will begin on Monday as GPs are allowed to prescribe the drugs for the first time.
Around 220,000 people with 'greatest need' are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years.
The drug is an antidiabetic drug which lowers blood sugar levels and and slows down how quickly food is digested.
From Monday, GPs in England will be allowed to prescribe Mounjaro to severely obese people who also suffer from a range of other health problems.
Patients previously needed to access the drugs through a special weight loss service.
But leading family doctors said some GPs have expressed concern about the additional workload linked to the rollout.
And pharmacy experts also said there could be pressure on supplies of the drug.
In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of over 40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea.
Estimates suggest around 1.5 million people in the UK are already taking weight loss drugs, which may have been prescribed through specialist weight loss services or via private prescription.
Dr Claire Fuller, from NHS England, said: 'This is an important next step in the rollout of weight loss drugs, with community-based services now able to offer this treatment from today.
'We urgently need to address rising levels of obesity and prioritise support for those who are experiencing severe ill health – and greater access to weight loss drugs will make a significant difference to the lives of those people.
'These drugs are an important tool alongside the range of wraparound NHS support and advice on good nutrition and increasing physical activity, which will be vital in helping some people lose weight and reduce their risk of serious long-term conditions.
'While not everyone will be eligible for weight loss drugs, it's important that anyone who is worried about the impact of their weight on their health discusses the range of NHS support available with their healthcare professional.'
Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'While we recognise the potential benefits of weight loss drugs, we know many GPs are concerned about the implications of the rollout of weight loss drugs into general practice, both in terms of workload and training to appropriately initiate and manage these treatments.
'The college shares these concerns, which is why we were pleased NHS England suggested a phased roll-out of Mounjaro as a treatment for weight loss. As and when this is escalated, appropriate resourcing for general practice – including access to 'wraparound' services – and training for GPs must follow.
GLP-1s like #Ozempic, #Saxenda, #Wegovy, or #Mounjaro are not an easy #weightloss hack.
Find out more about:🔵what they are ❓🔵how they're used 💊🔵who they help 💪
🔗Learn more: https://t.co/GY4a7VRAgF pic.twitter.com/Agiav8ryfU
— EU Medicines Agency (@EMA_News) January 4, 2025
She added: 'GPs and our teams are already working under intense workload and workforce pressures, and this must be factored into this rollout in order to guarantee it can be delivered safely.
'More widely, whilst weight loss medications have a lot of potential benefits for patients who are struggling to lose weight and who meet all the clinical criteria for a prescription, they mustn't be seen as a 'silver bullet' to aid weight loss.
'We also need to see a focus on prevention, stopping people becoming overweight in the first place so they don't require a medical intervention later.'
Dr Hawthorne said there is no 'one size fits all approach' and that the rollout of the jabs should not 'come at the expense of other weight loss service'.
She continued: 'The roll-out of weight loss medications in the NHS will need to be consistently evaluated to ensure that there is evidence that these prescriptions are of long-term benefit to patients.'
Olivier Picard, chairman of the National Pharmacy Association, said: 'The demand for weight loss jabs continues to rise sharply, and more GPs have been directing patients back to pharmacies after initial inquiries, to access these treatments privately.
'As the NHS is now moving to implement National Institute for Health and Care Excellence (Nice) guidance, and tirzepatide becomes prescribable to more patients, we expect to see prescription volumes increase rapidly.
'However, NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately from a pharmacy.
'Pharmacists are experts in medication and many of us have lots of experience delivering weight loss injections as part of a package of care including lifestyle advice.
'We are well placed to help roll out weight loss treatment on the NHS, with the right funding to support it.
'The biggest concern we have is that prescribing these medications alone misses the point.
'They should be part of a comprehensive weight management strategy – combining lifestyle coaching, exercise, and nutritional guidance. In reality, many GPs lack the bandwidth to deliver the level of support needed to ensure proper understanding and follow-up.
'As a result, we could end up in a situation where patients are prescribed the medication, lose weight, and then experience rebound weight gain once the course ends – simply because the foundational lifestyle changes weren't addressed.'
Around 29% of the adult population in the UK is obese.
Health Secretary Wes Streeting said: 'Obesity is now one of the leading causes of ill health, costing the NHS billions. Yet we now have the science, technology, and knowledge to end the obesity epidemic, if we seize this opportunity.
'Obesity jabs are used by 1.5 million people in the UK, mainly through private prescriptions. The NHS was founded on a promise to 'universalise the best', and this Government is determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay.
'This rollout is an important step in making these medicines more widely available, and beginning to shift the focus of healthcare from sickness to prevention, which our forthcoming 10-year plan will deliver.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Stourbridge care home donates life-saving equipment to school
A STOURBRIDGE care home has donated a potentially life-saving piece of equipment to a primary school. Parkfield Grange care home gifted a bleed control kit to Netherbrook Primary School. The kit, which contains equipment to stop severe bleeding, will be used in emergency situations. Catherine Marshall, assistant head teacher at Netherbrook Primary School, said: "We were absolutely thrilled when a parent of two of our pupils, who works at Parkfield Grange Care Home, shared our fundraising plans with Emily Hocking, the home admissions advisor. "Emily kindly reached out and generously donated a bleed control kit. "We cannot thank Parkfield Grange enough for helping us access this vital emergency equipment that could one day save lives. "This donation not only enhances the safety of our pupils and staff but also means we're better prepared to support our wider community in the event of an emergency." Emily Hocking, home admissions advisor at Parkfield Grange, said: "We are part of a vibrant and caring community and when our colleague informed us of Netherbrook's plan to raise funds for a bleed control kit, we were delighted to donate one. "Having such a kit in a community setting can save lives before paramedics arrive." Parkfield Grange, which is located on the Hagley Road in Stourbridge, offers 68 large en-suite bedrooms and six one-bedroom care suites, all furnished. The care suites include an en-suite bedroom, lounge, and kitchenette and although developed with couples in mind, are ideal for those looking for more space and privacy than a traditional care bedroom.
Yahoo
19 minutes ago
- Yahoo
'Wholehearted apology' following tragic death of 25-year-old
A health boss has apologised 'wholeheartedly' following the inquest into the tragic death of a 25-year-old. Jodie Bailey, from Farnworth, died on Valentine's Day in 2022 at Royal Bolton Hospital. The jury highlighted a "serious failing" in her death. Ms Bailey was detained under the Mental Health Act at Honeysuckle Lodge at the hospital at the time of her death. READ MORE: 'Missed opportunity' in death of Farnworth woman aged 25 Family raise care concerns after Farnworth woman's death aged 25 Inquest jury highlights 'serious failing' in death of Farnworth woman The jury conclusion stated: "On the evidence available, her death was due to a combined effect of prescribed medications and the likely taking of additional illicit pregabalin, resulting in respiratory depression. "It cannot be determined when or where she took illicit pregabalin or where this came from. "There was a serious failing to review the prescribed medication alongside a qualified pharmacist and advise Jodie on the risk of polypharmacy. "Procedural failings possibly contributed to Jodie's death, such as the lack of documented communication between professionals involved in Jodie's care, alongside emergency protocols not being correctly followed." The jury gave a short form conclusion of a drug-related death. Paula Solomon, Deputy Chief Nurse at Greater Manchester Mental Health NHS Foundation Trust, said: 'On behalf of Greater Manchester Mental Health NHS Foundation Trust), I would like to express my heartfelt condolences to Jodie's family and all who cared for her and apologise wholeheartedly for the shortcomings identified in the care and treatment the Trust provided. 'Following this tragic incident, a thorough investigation was carried out and a number of improvements have been made in collaboration with our service users and their families. 'The Trust has a new executive team, and it is absolutely committed to transforming how we care for our service users. 'Our thoughts remain with everyone who was affected by this tragedy.'
Yahoo
an hour ago
- Yahoo
GPs can prescribe weight loss jabs on the NHS from today - but strict eligibility criteria in place
GPs will be able to prescribe weight loss jabs on the NHS from today. About 220,000 people with the "greatest need" are set to receive Mounjaro - with strict criteria for the first year of the rollout. Initially, only those with a body mass index of over 40 who have at least four other health problems linked to obesity will be eligible. Some doctors have raised concerns about the additional workload this new programme will bring, while pharmacists fear it could lead to supply shortages. While an estimated 1.5 million people are now taking weight loss drugs across the UK, they could previously only be accessed through specialist services or private prescriptions. Dr Claire Fuller from NHS England said: "We urgently need to address rising levels of obesity and prioritise support for those who are experiencing severe ill health - and greater access to weight loss drugs will make a significant difference to the lives of those people." She added: "While not everyone will be eligible for weight loss drugs, it's important that anyone who is worried about the impact of their weight on their health discusses the range of NHS support available with their healthcare professional." The chairwoman of the Royal College of GPs welcomed NHS England's decision to pursue a phased rollout, and said current workloads must be factored in to ensure the jabs can be prescribed safely. Professor Kamila Hawthorne went on to say: "While weight loss medications have a lot of potential benefits for patients who are struggling to lose weight and who meet all the clinical criteria for a prescription, they mustn't be seen as a 'silver bullet' to aid weight loss. "We also need to see a focus on prevention, stopping people becoming overweight in the first place so they don't require a medical intervention later." Read more from Sky News:UK and NATO allies to boost defence spending Her remarks were echoed by the National Pharmacy Association's chairman Olivier Picard, who says "prescribing these medications alone misses the point". He argued that they need to be part of a comprehensive strategy that includes lifestyle coaching, exercise and nutritional guidance - but many GPs currently "lack the bandwidth" to provide this support. "As a result, we could end up in a situation where patients are prescribed the medication, lose weight, and then experience rebound weight gain once the course ends - simply because the foundational lifestyle changes weren't addressed," Mr Picard added. Estimates suggest about 29% of the adult population is obese. Health Secretary Wes Streeting says the government "is determined to bring revolutionary modern treatments to everyone who needs them, not just those who can afford to pay".
